NEWS
Our Latest News
ARCHIMED Pharma Services announces the spin-off of portfolio company Suanfarma’s subsidiary, SuanNutra
The corporate carve-out is part of Suanfarma’s strategy to aggressively build its core business in the active pharmaceutical ingredient market. SuanNutra, which accounts for approximately a quarter of Suanfarma’s sales, is a scalable, globally recognized leader in the nutraceutical ingredients sector.
ARCHIMED’s MED II sells DIESSE, returning 4.6x to shareholders
January
27,
2025
ARCHIMED earns 5x its investment, selling a majority of Ad-Tech to Tokyo-listed Nihon Kohden
November
26,
2024
ARCHIMED acquires SeqCenter, a fast-growing player in cutting-edge DNA and RNA gene sequencing
November
8,
2024
368